Cited by 422Autoimmune Neurological Disorders and TreatmentsHerpesvirus Infections and TreatmentsPeripheral Neuropathies and Disorders

N‐methyl‐ D ‐aspartate receptor antibodies in herpes simplex encephalitis

Open access
Prüss, Harald, Finke, Carsten, Höltje, Markus, Hofmann, Joerg, Klingbeil, Christine, Probst, Christian, Borowski, Kathrin, Ahnert‐Hilger, Gudrun +7 more·2012·Annals of Neurology

Abstract

Objective: To determine the presence and kinetics of antibodies against synaptic proteins in patients with herpes simplex virus encephalitis (HSE). Methods: Retrospective analysis of 44 patients with polymerase chain reaction‐proven HSE for the presence of a large panel of onconeuronal and synaptic receptor antibodies. The effect of patients' serum was studied in cultures of primary mouse hippocampal neurons. Results: N‐Methyl‐ D ‐aspartate receptor (NMDAR) antibodies of the immunoglobulin (Ig) subtypes IgA, IgG, or IgM were detected in 13 of 44 patients (30%) in the course of HSE, suggesting secondary autoimmune mechanisms. NMDAR antibodies were often present at hospital admission, but in some patients developed after the first week of HSE. Antibody‐positive sera resulted in downregulation of synaptic marker proteins in hippocampal neurons. Interpretation: Some patients with HSE develop IgA, IgG, or IgM autoantibodies against NMDAR. Sera from these patients alter the density of neuronal synaptic markers, suggesting a potential pathogenic disease‐modifying effect. These findings have implications for the understanding of autoimmunity in infectious diseases, and prospective studies should reveal whether the subgroup of patients with HSE and NMDAR antibodies may benefit from immunotherapy. ANN NEUROL 2012;72:902–911

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.23689

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rapidly progressive alterations of memory, behavior, cognition, and psychosis previously thought to be idiopathic or viral-induced are now known to be autoimmune.

    “Rapidly progressive alterations of memory, behavior, cognition, and psychosis previously thought to be idiopathic or viral-induced are now known to be autoimmune.20-23”

    From Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study (2013) · cites this paper as [23]

    The Abstract’s Interpretation and the Discussion report NMDAR autoantibodies in some patients with herpes simplex encephalitis and suggest that autoimmunity may contribute to their symptoms. They do not establish that the listed memory, behavioral, cognitive, and psychotic symptoms—previously considered idiopathic or viral-induced—are now known to be autoimmune; the Discussion says clinical differences between antibody-positive and antibody-negative patients were not established. Page numbers are unavailable in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 21

  1. [1]Steiner I Kennedy PG Pachner AR The neurotropic herpes viruses: herpes simplex and varicella-zoster Lancet Neurol 2007 6 1015 1028 17945155
  2. [2]Whitley R Sheld W Whitley R C Marra Herpes simplex virus Infections of the central nervous system 2004 Philadelphia, PA Lippincott Williams & Wilkins 123 144
  3. [3]Raschilas F Wolff M Delatour F Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study Clin Infect Dis 2002 35 254 260 12115090
  4. [4]Sellner J Dvorak F Zhou Y Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis Neurosci Lett 2005 374 197 202 15663962
  5. [5]Kamei S Sekizawa T Shiota H Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis J Neurol Neurosurg Psychiatry 2005 76 1544 1549 16227548 PMC1739396
  6. [6]Meyding-Lamade UK Oberlinner C Rau PR Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities J Neurovirol 2003 9 118 125 12587075
  7. [7]Skoldenberg B Aurelius E Hjalmarsson A Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults J Neurol 2006 253 163 170 16222428
  8. [8]De Tiege X Rozenberg F Des Portes V Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities Neurology 2003 61 241 243 12874408
  9. [9]Ropper A Brown R Adams and Victor’s principles of neurology 2009 9th ed New York, NY McGraw-Hill
  10. [10]Wandinger KP Saschenbrecker S Stoecker W Dalmau J Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis J Neuroimmunol 2010 231 86 91 20951441
  11. [12]Reiber H Ungefehr S Jacobi C The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis Mult Scler 1998 4 111 117 9762657
  12. [13]Höltje M Djalali S Hofmann F A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation FASEB J 2009 23 1115 1126 19047066
  13. [14]Prüss H Höltje M Maier N IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment Neurology 2012 78 1743 1753 22539565 PMC3359581
  14. [15]Prüss H Dalmau J Harms L Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin Neurology 2010 75 1735 1739 21060097
  15. [16]Manto M Dalmau J Didelot A In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction Orphanet J Rare Dis 2010 5 31 21110857 PMC3002330
  16. [17]Davies G Irani SR Coltart C Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit Crit Care Med 2010 38 679 682 20016378
  17. [18]Finke C Kopp UA Prüss H Cognitive deficits following anti-NMDA receptor encephalitis J Neurol Neurosurg Psychiatry 2011 83 195 198 21933952 PMC3718487
  18. [19]Gable MS Sheriff H Dalmau J The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project Clin Infect Dis 2012 54 899 904 22281844 PMC3297648
  19. [20]Dalmau J Lancaster E Martinez-Hernandez E Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis Lancet Neurol 2011 10 63 74 21163445 PMC3158385
  20. [21]Gable M Gavali S Radner A Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis Eur J Clin Microbiol Infect Dis 2009 28 1421 1429 19718525 PMC2773839
  21. [22]Granerod J Ambrose HE Davies NW Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study Lancet Infect Dis 2010 10 835 844 20952256

Cited by

Sorted by citations

Authors
Prüss, H., Finke, C., Höltje, M., Hofmann, J., Klingbeil, C., Probst, C., Borowski, K., Ahnert‐Hilger, G., Harms, L., Schwab, J. M., Ploner, C. J., Komorowski, L., Stoecker, W., Dalmau, J., & Wandinger, K.
Affiliations
  • Charité – Universitätsmedizin Berlin (DE)
  • Institució Catalana de Recerca i Estudis Avançats (ES)
  • Universität Hamburg (DE)
Corresponding author
Prüss, Harald
Venue
Annals of Neurology
Publisher
Wiley
Published
2012-12
Volume
72
Issue
6
Pages
902-911
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2016421065
Cited by
422
References
1
Citations by year
2026: 22 · 2025: 24 · 2024: 18 · 2023: 22 · 2022: 30 · 2021: 26 · 2020: 31 · 2019: 27 · 2018: 28 · 2017: 39 · 2016: 39 · 2015: 45 · 2014: 35 · 2013: 26 · 2012: 8
FWCI
22.45
Type
journal article
Language
en
Open access
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Mental Health (R01MH094741)
  • National Cancer Institute (R01CA089054, R01CA107192)
  • National Institute of Neurological Disorders and Stroke (R01NS077851)
Topics
  • Health Sciences › Medicine › Neurology › Autoimmune Neurological Disorders and Treatments
  • Health Sciences › Medicine › Epidemiology › Herpesvirus Infections and Treatments
  • Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
Keywords
herpes simplex encephalitis, NMDA receptor antibodies, autoimmune encephalitis, IgA autoantibodies, IgG autoantibodies, IgM autoantibodies, hippocampal neurons, immunotherapy
MeSH terms
Adolescent, Adult, Aged, Animals, Antibodies, Cells, Cultured, Child, Embryo, Mammalian, Female, Hippocampus, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neurons, Transfection, Receptors, N-Methyl-D-Aspartate, Synapsins, Encephalitis, Herpes Simplex, Mice, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review